A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Derek Stefureac has run at least one marathon on all 7 seven continents — and says it helps keep the "MS symptoms at bay" ...

Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Copenhagen this week is celebrating its 40th edition. In recognition of this landmark, the ...

This explanation challenges the results from previous randomised controlled trials and the efficacy of all approved drugs, ...

Communicating my experience with MS is important, columnist Ben Hofmeister says, but so is making sure the other person comprehends it.

Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

Continuous treatment with Briumvi (ublituximab) over five years was associated with low rates of relapses and confirmed ...